Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

F. Efficace, F. Stagno, A. Iurlo, M. Breccia, F. Cottone, M. Bonifacio, E. Abruzzese, F. Castagnetti, G. Caocci, M. Crugnola, I. Capodanno, B. Martino, M. Tiribelli, A. Patriarca, A. Gozzini, P. Pregno, S. Saussele, N. Cascavilla, C. Fozza, M. BergamaschiG. Binotto, M. Vignetti, G. Rosti

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)488-498
Number of pages11
JournalLeukemia
Volume34
Issue number2
DOIs
Publication statusPublished - 2020

Cite this

Efficace, F., Stagno, F., Iurlo, A., Breccia, M., Cottone, F., Bonifacio, M., Abruzzese, E., Castagnetti, F., Caocci, G., Crugnola, M., Capodanno, I., Martino, B., Tiribelli, M., Patriarca, A., Gozzini, A., Pregno, P., Saussele, S., Cascavilla, N., Fozza, C., ... Rosti, G. (2020). Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy. Leukemia, 34(2), 488-498. https://doi.org/10.1038/s41375-019-0563-0